Effects of Y2O3 and LiAl5O8 on the Microstructure and Optical Properties of Reactively Sintered AlON Based Transparent Ceramics

Sintering aid was very crucial to influence the microstructure and thus the optical property of the sintered optical ceramics. The purpose of this work was to explain the difference between the sintering aids of Li⁺ and Y³⁺ on Al₂₃O₂₇N₅ (AlON) ceramic via reaction sintering method. The effects of LiAl₅O₈ (LA) and Y₂O₃ on the sintering of Al₂O₃-AlN system were carefully compared, in terms of X-ray diffraction (XRD), microstructure, density, X-ray photoelectron spectroscopy (XPS) and optical transmittance. According to the XPS and XRD lattice analysis, the chemical structure of the materials was not obviously affected by different dopants. We firstly reported that, there was obvious volume expansion in the Y³⁺ dopped AlON ceramics, which was responsible for the low transparency of the ceramics. Obvious enhancements were achieved using Li⁺ aids from the results that Li: AlONs showing a higher transparency and less optical defects. A higher LA content (20 wt%) was effective to remove pores and thus obtain a higher transmittance (~86.8% at ~3.5 μm). Thus, pores were the main contributions to the property difference between the dopant samples. The importance of sintering aids should be carefully realized for the reaction sintering fabrication of AlON based ceramics towards high transparency.

[Rapamycin in the treatment of renal diseases associated with tuberous sclerosis complex]

Objective: To investigate the efficacy and safety of rapamycin in children with tuberous sclerosis complex (TSC) associated renal disease. Methods: A prospective self-control study was conducted. The clinical data of 92 children diagnosed with tuberous sclerosis complex associated kidney disease at the People's Liberation Army General Hospital from January 2011 to January 2019 were collected. The long-term rapamycin treatment for all patients initiated at 1 mg/(m(2)·d), which was gradually adjusted to reach a blood concentration of 5-10 μg/L. The changes of the maximum diameter of renal lesions in children after rapamycin treatment were observed and analyzed with Wilcoxon test. Results: Ninety-two children, including 52 males and 40 females, who met the criteria were analyzed. Sixty patients had only renal angiomyolipoma(RAML), while 24 patients had only multiple renal cysts(MRC), and 8 patients had both lesions. The age of TSC diagnosis was 16.0 (7.0, 42.0) months, and the age of initial treatment with rapamycin was 63.5 (21.0, 103.0) months. The follow-up lasted for 12.0 (4.0, 23.0) months. Sequencing of TSC1 and TSC2 genes was performed in 54 children with TSC, including 3 patients (6%) with mutations in TSC1 gene and 51 patients (94%) with mutations in TSC2 gene. The maximum RAML diameter before treatment was 7.0 (4.0, 9.0) mm. The best effect reached at 3 months of treatment, with the diameter of 4.0 (0,7.0) mm. The maximum diameters at 6 months, 1 year and 1-2 years were 5.0 (0,9.8) mm, 5.0 (1.5, 8.5) mm, 5.5 (3.0, 9.0) mm, respectively, and were significantly different from the baseline (Z=-2.404,-2.350,-2.750,P=0.016,0.019,0.006, respectively). The maximum diameter after 2-3 years, and ≥3 years were 5.0 (3.9,7.0) mm and 6.0 (1.0, 11.0) mm, without significant difference from the baseline (Z=-0.856,-0.102,P=0.393,0.919, respectively).The maximum diameters of MRC after 3 months, 6 months, 1 year,1-2 years, 2-3 years, and ≥3 years were 11.0 (5.0, 14.0) mm,3.0 (0.0,11.0) mm,5.0 (0,21.0) mm,0 (0,14.0) mm,0 (0,10.0) mm, and 0 (0,18.3) mm, respectively, but were not significantly different rom the baseline (7.0 (5.0, 15.7) mm)(Z=-0.944,-1.214,-1.035,-1.896,-1.603,-1.214,P=0.345,0.225,0.301,0.058,0.109,0.225, respectively).Twenty-nine patients (32%) had oral ulcers during the entire treatment period, and no serious adverse reactions were observed. Conclusions: Rapamycin could decrease the diameter of TSC-related RAML, but could not inhibit the growth of cysts. It is well tolerated in the treatment of renal diseases associated with tuberous sclerosis complex.

Time-varying, slow-phase component interaction in congenital nystagmus

We investigated the nystagmus of a 12-year-old boy with suspected X-linked congenital nystagmus (CN) and exophoria to determine the underlying mechanisms and component signals in the 'dual-velocity' and other slow phases of his Asymmetric (a)Periodic Alternating Nystagmus (APAN). Fast Fourier transforms (FFT) were performed on the waveforms and residual data after subtracting a sawtooth waveform whose amplitude and frequency matched those of the jerk nystagmus. The FFT analyses identified two frequency components (jerk--4 Hz and pendular--4 and 8 Hz, variable) that varied differently in intensity and frequency/phase over the time-course of the APAN. We synthesized each of the patient's slow phases using summation of sawtooth and sinusoidal waveforms. The resulting waveforms included jerk (with different slow-phase appearances), dual jerk, and pendular. We demonstrated that the pendular nystagmus seen during the neutral phase of APAN and the appearance of either decelerating (mimicking latent nystagmus), dual-velocity, or dual-jerk slow phases can be explained and produced by the summation of linear and pendular components of variable amplitudes and frequencies/phases. Thus, one mechanism may be responsible for all the variation seen in this patient's slow phases, rather than the less parsimonious hypothesis of a switched-tonic-imbalance mechanism that we had originally suggested to simulate the dual-velocity waveform.